Besides, the qPCR and Western blotting revealed that Se-Met supplementation reduced the production of ADAMTS-5 and MMP-13, and promoted the secretion of Aggrecan and Col-2, while knockdown of SelK aggravated ECM metabolic disorders (Fig. 5D, G, H). This evidence concerns the gene MMP13 and metabolic disease.